Transmission Inference Using Pathogen Genomes

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

Pathogen genome sequencing enables transmission inference by measuring genetic distance between isolates, where closely related genomes suggest recent epidemiological linkage.
The practical next step is to combine genomic data with epidemiological metadata, including collection dates, locations, and exposure histories, before drawing transmission conclusions.
A critical limitation is that sampling bias and unsampled intermediate hosts can create gaps that make transmission chains appear disconnected or falsely connected.

At a Glance

Concept	Definition	Application to Transmission Inference	Key Limitation
Genetic distance	Number of nucleotide differences between pathogen genomes	Smaller distances suggest recent common ancestry and possible direct transmission	Mutation rates vary by species and lineage, so distance thresholds are not universal
Mutation rate	Rate at which substitutions accumulate over time	Used to estimate time since divergence between isolates	Rates are estimates with confidence intervals and can change under selective pressure
Sampling density	Proportion of actual cases represented by sequenced isolates	Higher density improves resolution of transmission chains	Gaps in sampling can create false breaks or false links in inferred chains
Phylogenetic clustering	Grouping of isolates based on shared ancestry	Clusters may represent outbreaks or transmission networks	Clusters can also reflect shared environmental sources instead of direct person-to-person spread

The Role of Pathogen Genomes in Transmission Inference

Transmission inference using pathogen genomes is a core activity in infectious disease epidemiology. The central premise is that pathogens accumulate mutations as they replicate and spread. When two clinical isolates share a recent common ancestor, their genomes will be more similar than isolates that diverged long ago. By comparing whole-genome sequences, researchers can reconstruct likely transmission pathways and identify outbreaks that might otherwise go unnoticed.

The approach has become standard in public health laboratories and research settings. It is used for bacteria such as Mycobacterium tuberculosis, Salmonella enterica, and methicillin-resistant Staphylococcus aureus. The same principles apply to viral pathogens, though the mutation rates and genome structures differ.

The value of genomic inference lies in its ability to distinguish between cases that are epidemiologically linked and those that are not. Traditional contact tracing relies on interviews and records. Genomic data adds an independent line of evidence. When a patient reports no contact with another case, but their isolates are nearly identical, the genomic data may indicate an unrecognized link. Conversely, when isolates are genetically distant, a suspected link may be ruled out.

The workflow begins with isolate collection and DNA extraction. The genome is then sequenced and assembled. The resulting sequences are compared to a reference genome or to each other. The output is a measure of genetic distance, often expressed as the number of single nucleotide variants (SNVs) or single nucleotide polymorphisms (SNPs). These distances are then interpreted in the context of epidemiological data.

The interpretation is not straightforward. A single SNP difference between two isolates does not prove direct transmission. The isolates could share a common source that was not sampled. The mutation rate of the organism determines how quickly differences accumulate. For slowly evolving organisms, a single SNP difference may represent years of divergence. For rapidly evolving organisms, the same difference may represent days.

The field has matured to the point where genomic data are used in real time during outbreaks. Public health agencies use these data to guide control measures. The same methods are used in hospitals to detect healthcare-associated transmission. The approach is also used in food safety to link clinical cases to contaminated products.

The remainder of this article explains the core concepts, the practical workflow, and the limitations that must be considered when interpreting genomic data for transmission inference.

Core Concepts in Genomic Transmission Inference

Genetic Distance and Its Measurement

Genetic distance is the foundation of transmission inference. It is a quantitative measure of the number of differences between two genomes. The most common measure is the number of single nucleotide variants (SNVs) or single nucleotide polymorphisms (SNPs). These are positions in the genome where the nucleotide base differs between two isolates.

The measurement requires a reference point. The reference can be a well-characterized genome of the same species, or it can be a consensus sequence generated from the study population. The choice of reference affects the results. A reference that is distantly related to the study isolates will introduce more apparent differences than a reference that is closely related.

The quality of the sequencing data also affects the measurement. Low coverage sequencing produces errors that can be mistaken for true variants. The analysis pipeline must include quality filters to remove low-confidence calls. The use of standardized pipelines is important for reproducibility across laboratories.

The distance between two isolates is not a direct measure of transmission. It is a measure of the number of mutations that have accumulated since the isolates shared a common ancestor. The mutation rate determines how many mutations are expected over a given time period. If the mutation rate is known, the genetic distance can be converted into an estimate of time since divergence.

Mutation Rates and Molecular Clocks

The mutation rate is the rate at which new mutations appear in the genome. It is usually expressed as substitutions per site per year. The rate varies by species and by lineage. Some bacteria have mutation rates that are relatively stable, while others have rates that change under selective pressure.

The molecular clock is the concept that mutations accumulate at a roughly constant rate over time. If the clock is accurate, the genetic distance between two isolates can be used to estimate the time since they diverged. This estimate is called the time to most recent common ancestor (TMRCA).

The clock is not perfect. Mutation rates can be influenced by the environment, the host, and the presence of antimicrobial agents. The rate can also change during the course of an infection. For example, a chronic infection may accumulate more mutations than an acute infection. The clock must be calibrated for each species and each study.

The use of a molecular clock requires a reliable estimate of the mutation rate. This estimate is usually derived from studies of known transmission events or from laboratory evolution experiments. The estimate has a confidence interval. The confidence interval must be considered when interpreting the results.

Sampling and Its Impact on Inference

Sampling is the process of selecting isolates for sequencing. The completeness of sampling determines the resolution of the inference. If all cases in an outbreak are sampled, the transmission chain can be reconstructed with high confidence. If only a fraction of cases are sampled, the chain will have gaps.

The gaps can be misinterpreted. A missing intermediate case can make two isolates appear to be directly linked when they are not. A missing case can also break a chain that is actually continuous. The direction of transmission can be difficult to determine when the source is not sampled.

The sampling strategy should be designed to maximize the likelihood of capturing the transmission chain. This includes sampling cases with different onset dates, different locations, and different risk factors. The sampling should also include potential sources, such as food products, environmental samples, or animal hosts.

The sampling bias is a major limitation of genomic inference. The results are only as good as the sampling. A study that samples only a small fraction of cases will produce a less reliable inference than a study that samples a large fraction. The sampling strategy should be documented and reported.

Methods for Transmission Inference

Whole-Genome Sequencing and Variant Calling

Whole-genome sequencing (WGS) is the primary method for generating genomic data for transmission inference. The process begins with the extraction of DNA from a pure culture. The DNA is then fragmented and sequenced. The resulting reads are aligned to a reference genome.

The alignment is followed by variant calling. This step identifies the positions where the isolate differs from the reference. The variants are then filtered to remove low-quality calls. The result is a set of high-confidence variants that can be used for comparison.

The quality of the variant calls depends on the sequencing depth. A higher depth provides more confidence in the calls. The depth should be sufficient to distinguish true variants from sequencing errors. The recommended depth varies by the platform and the organism.

The alignment and variant calling are performed using bioinformatics tools. The tools are available as open-source software. The choice of tools can affect the results. The use of a standardized pipeline is recommended to ensure reproducibility.

Phylogenetic Analysis and Tree Construction

Phylogenetic analysis is used to infer the evolutionary relationships between isolates. The analysis is based on the genetic distances between the isolates. The result is a tree that shows the likely ancestry of the isolates.

The tree is constructed using a method such as maximum likelihood or Bayesian inference. The method uses a model of sequence evolution to estimate the likelihood of the tree. The tree is then used to identify clusters of isolates that share a recent common ancestor.

The tree is not a direct representation of transmission. It is a representation of genetic relationships. The transmission chain must be inferred from the tree in the context of epidemiological data. The tree can show which isolates are closely related, but it cannot show who infected whom.

The tree is also affected by the sampling. A tree that includes only a small number of isolates will have less resolution than a tree that includes many isolates. The tree should be interpreted with caution when the sampling is incomplete.

Cluster Detection and Outbreak Identification

Cluster detection is the process of identifying groups of isolates that are more closely related to each other than to other isolates. The clusters are defined by a threshold of genetic distance. The threshold is often set based on the mutation rate of the species.

A cluster may represent an outbreak. The cluster is then investigated to determine if the cases are epidemiologically linked. The investigation includes interviews, record reviews, and environmental sampling.

The cluster detection is a screening tool. It identifies potential outbreaks that require further investigation. The cluster detection is not a confirmation of transmission. The confirmation requires the integration of genomic and epidemiological data.

The cluster detection is also affected by the sampling. A cluster that is identified in a small sample may not be a true cluster. The cluster may be an artifact of the sampling. The cluster should be validated with additional data.

Practical Workflow for Transmission Inference

Step 1: Define the Study Question and Population

The first step is to define the study question. The question determines the design of the study and the analysis. The question can be about a specific outbreak, a transmission chain, or a population-level pattern.

The study population is defined by the question. The population can be a group of patients in a hospital, a group of cases in a community, or a group of isolates from a food product. The population should be defined by clear criteria.

The study question also determines the sampling strategy. The sampling should be designed to answer the question. The sampling should include the cases that are relevant to the question.

Step 2: Collect and Prepare Isolates

The isolates are collected from the study population. The collection should follow the biosafety guidelines for the organism. The isolates should be stored and transported according to the guidelines.

The isolates are then prepared for sequencing. The preparation includes the extraction of DNA and the quality assessment of the DNA. The DNA should be of sufficient quality and quantity for sequencing.

The preparation should be documented. The documentation should include the source of the isolate, the date of collection, and the method of preparation. The documentation is important for the interpretation of the results.

Step 3: Sequence and Generate Genomic Data

The sequencing is performed using a platform that is appropriate for the organism. The sequencing should be performed according to the manufacturer's instructions. The sequencing should be performed in a laboratory that is qualified for the procedure.

The sequencing generates reads that are then processed. The processing includes the removal of low-quality reads and the alignment to a reference genome. The processing should be performed using a standardized pipeline.

The quality of the sequencing should be assessed. The assessment includes the depth of coverage and the quality of the reads. The assessment should be documented.

Step 4: Perform Variant Calling and Distance Calculation

The variant calling is performed to identify the differences between the isolates. The variant calling should be performed using a standardized method. The method should be validated for the organism.

The distance between the isolates is calculated from the variants. The distance is the number of variants that differ between the isolates. The distance is used to construct the phylogenetic tree.

The distance should be interpreted in the context of the mutation rate. The distance should be converted into a time estimate if the mutation rate is known.

Step 5: Integrate Epidemiological Data

The genomic data should be integrated with the epidemiological data. The epidemiological data includes the time, location, and exposure history of the cases. The integration is performed to confirm or refute the transmission.

The integration is performed using a statistical method. The method can be a simple comparison of the genomic and epidemiological data. The method can also be a more complex model that incorporates both types of data.

The integration should be performed by a team that includes both genomic and epidemiological expertise. The team should interpret the results in the context of the study question.

Step 6: Interpret and Report Results

The results should be interpreted in the context of the study question. The interpretation should consider the limitations of the data. The interpretation should be reported in a clear and transparent manner.

The report should include the methods, the results, and the limitations. The report should also include the recommendations for action. The recommendations should be based on the evidence.

The report should be shared with the relevant stakeholders. The stakeholders include the public health authorities, the clinical team, and the laboratory. The report should be used to guide the response to the outbreak.

Options and Tradeoffs in Methods

Whole-Genome Sequencing versus Targeted Sequencing

Whole-genome sequencing provides the highest resolution for transmission inference. It captures the entire genome of the organism. The resolution is sufficient to distinguish between isolates that are closely related.

Targeted sequencing is a more limited approach. It sequences only a portion of the genome. The portion is often a set of genes that are known to be variable. The resolution is lower than that of whole-genome sequencing.

The choice between the two methods depends on the study question and the resources. Whole-genome sequencing is more expensive and requires more computational resources. Targeted sequencing is less expensive and can be performed more quickly.

The tradeoff is between resolution and cost. The whole-genome sequencing is preferred for the investigation of outbreaks. The targeted sequencing is preferred for the screening of large numbers of isolates.

Single Nucleotide Variants versus Other Genetic Markers

The single nucleotide variant is the most common marker for transmission inference. It is a single base change in the genome. The variant is easy to identify and compare.

Other markers include insertions and deletions, and structural variants. These markers are less common but can provide additional information. The markers can be used to distinguish between isolates that have the same SNV profile.

The choice of marker depends on the organism and the question. The SNV is the most widely used marker. The other markers are used when the SNV does not provide enough resolution.

The markers should be used in combination. The combination provides a more complete picture of the genetic relationship between the isolates.

The Role of Reference Genomes

The reference genome is the basis for the comparison. The reference is a genome that is used as a standard. The reference can be a well-characterized genome of the same species.

The choice of reference affects the results. A reference that is closely related to the study isolates will produce a smaller number of variants. A reference that is distantly related will produce a larger number of variants.

The reference should be chosen carefully. The reference should be representative of the study population. The reference should be of high quality.

The reference can also be a problem. The reference may not be available for a new or emerging organism. In this case, a de novo assembly can be used. The de novo assembly is a more complex process.

Observations and Measurements

What to Record in a Transmission Inference Study

The records are the foundation of the analysis. The records should be complete and accurate. The records should include the following:

The identification of the isolate, including the species and the strain.
The date and location of the collection.
The source of the isolate, such as a clinical specimen or an environmental sample.
The method of the isolation and the culture.
The quality of the DNA and the sequencing.
The variant calls and the genetic distances.
The epidemiological data for the cases.

The records should be stored in a secure and accessible format. The records should be reviewed and validated. The records should be available for the interpretation of the results.

How to Assess the Quality of the Data

The quality of the data is a key factor in the reliability of the inference. The quality should be assessed at each step of the workflow.

The quality of the isolates should be assessed. The isolates should be pure and viable. The isolates should be identified correctly.

The quality of the DNA should be assessed. The DNA should be of sufficient quantity and quality. The DNA should be free of contaminants.

The quality of the sequencing should be assessed. The sequencing should have sufficient depth and coverage. The reads should be of high quality.

The quality of the variant calls should be assessed. The calls should be validated. The calls should be reproducible.

The Role of Controls in the Analysis

The controls are used to validate the analysis. The controls include a positive control and a negative control.

The positive control is a sample that is known to be positive. The control is used to validate the method. The control should produce the expected result.

The negative control is a sample that is known to be negative. The control is used to detect contamination. The control should produce no result.

The controls should be included in each run. The controls should be documented. The controls should be used to assess the quality of the run.

Common Failure Patterns

Overinterpretation of Genetic Distance

A common failure is the overinterpretation of the genetic distance. The distance is a measure of the genetic difference. The distance is not a direct measure of the transmission.

A small distance does not prove transmission. The distance can be small because the isolates share a common source. The distance can also be small because the mutation rate is low.

A large distance does not rule out transmission. The distance can be large because the isolates have been separated for a long time. The distance can also be large because the mutation rate is high.

The distance should be interpreted in the context of the mutation rate and the epidemiological data. The distance should not be used as the sole evidence of transmission.

Ignoring the Sampling Bias

The sampling bias is a common failure. The sampling bias is the difference between the sampled isolates and the true population. The bias can lead to incorrect conclusions.

The sampling bias can lead to a false cluster. The cluster can be an artifact of the sampling. The cluster can be misinterpreted as an outbreak.

The sampling bias can also lead to a false break in the chain. The break can be an artifact of the missing isolates. The break can be misinterpreted as a lack of transmission.

The sampling bias should be considered in the interpretation. The sampling should be designed to minimize the bias. The sampling should be documented.

Confusing Genetic Clustering with Transmission

A common failure is the confusion of genetic clustering with transmission. The genetic cluster is a group of isolates that are closely related. The cluster is not a proof of transmission.

The cluster can be caused by a shared source. The cluster can also be caused by a shared risk factor. The cluster can be caused by a sampling bias.

The transmission should be inferred from the cluster in the context of the epidemiological data. The transmission should be confirmed by the epidemiological investigation.

The cluster should be used as a screening tool. The cluster should not be used as a definitive proof of transmission.

The Use of an Inappropriate Molecular Clock

The molecular clock is a tool for estimating the time of divergence. The clock is not universal. The clock is calibrated for a specific organism and a specific context.

The use of an inappropriate clock can lead to a false estimate. The estimate can be too high or too low. The estimate can be misinterpreted.

The clock should be calibrated for the organism. The clock should be validated for the context. The clock should be used with caution.

The clock should be used in combination with other data. The clock should not be used as the sole evidence of the time of transmission.

Welfare and Safety Context

Biosafety in the Laboratory

The laboratory work with pathogens requires a high level of biosafety. The biosafety is the practice of preventing the exposure to the pathogen. The biosafety is the responsibility of the laboratory.

The biosafety guidelines are provided by the CDC and NIH Biosafety in Microbiological and Biomedical Laboratories. The guidelines describe the appropriate containment for the organism. The guidelines also describe the decontamination and the waste disposal.

The laboratory should follow the guidelines. The laboratory should be designed for the appropriate biosafety level. The laboratory should be equipped with the appropriate safety equipment.

The laboratory should be trained in the biosafety procedures. The training should be documented. The training should be updated.

The Use of Authenticated Materials

The use of authenticated materials is important for the quality of the analysis. The authenticated materials are the reference strains and the control strains. The materials are available from the American Type Culture Collection.

The authenticated materials are used to validate the methods. The materials are also used to ensure the quality of the results. The materials should be used in the analysis.

The materials should be stored and handled according to the instructions. The materials should be documented. The materials should be used in the appropriate biosafety level.

The Role of the Clinical and Laboratory Standards Institute

The Clinical and Laboratory Standards Institute provides the standards for the antimicrobial susceptibility testing. The standards are used to determine the susceptibility of the organism to the antimicrobial agents.

The standards are used in the context of the transmission inference. The susceptibility data can be used to support the inference. The data can also be used to guide the treatment.

The standards should be followed. The standards should be used in the laboratory. The standards should be documented.

Professional Escalation Criteria

The following criteria indicate that the analysis should be escalated to a higher level of expertise:

The analysis is being used to guide a public health action. The action should be based on the best available evidence.
The analysis is being used to inform a clinical decision. The decision should be based on the best available evidence.
The analysis is being used to identify a source of an outbreak. The source should be identified with a high level of confidence.
The analysis is being used to rule out a transmission. The ruling out should be based on a high level of confidence.
The analysis is being used to estimate the time of transmission. The estimate should be based on a validated molecular clock.
The analysis is being used to compare the results across different laboratories. The comparison should be based on a standardized method.

The escalation should be performed by the laboratory director or the responsible person. The escalation should be documented. The escalation should be performed in a timely manner.

A Practical Decision Framework for Genomic Transmission Inference

The Need for a Structured Decision Process

Genomic transmission inference produces outputs that require interpretation before they can guide public health action. The gap between raw genetic data and a defensible conclusion is where errors occur. A structured decision framework helps modelers and epidemiologists move from sequence data to a stated conclusion with documented reasoning. The framework described here is designed for use in outbreak investigations, hospital transmission studies, and foodborne illness source attribution. It is not a statistical model. It is a procedural checklist that forces explicit consideration of the evidence quality, the sampling context, and the alternative explanations before a transmission claim is made.

The framework is organized around a series of decision gates. Each gate requires a specific piece of evidence or a specific analysis step. The output of each gate determines whether the investigation proceeds, stops, or requires additional data. This structure is useful because it prevents the common failure of moving directly from a phylogenetic tree to a transmission conclusion without examining the underlying assumptions.

Gate 1: Establish the Baseline Genetic Diversity

The first decision gate requires an estimate of the baseline genetic diversity in the pathogen population being studied. This baseline is the range of genetic distances observed among isolates that are known to be epidemiologically unrelated. Without this baseline, any observed genetic distance is difficult to interpret. A distance that is small relative to the baseline may indicate a recent common ancestor. A distance that is large relative to the baseline may indicate that the isolates are not directly related.

The baseline can be established in several ways. The most direct method is to sequence isolates from cases that are known to be unrelated by time, location, and exposure history. These isolates provide a distribution of distances that represent the background variation in the population. A second method is to use published data from the same species and geographic region. A third method is to use a collection of isolates from the same environment or host population that were collected over a defined period.

The baseline should be recorded as a distribution, not a single value. The distribution includes the median distance and the range. The distribution is used to define a threshold for potential linkage. The threshold is not a universal number. It is specific to the organism, the geographic region, and the sampling period. The threshold should be documented in the study records.

The baseline also serves as a quality check. If the baseline diversity is unexpectedly high or low, the sequencing or the sampling may be flawed. The baseline should be reviewed before the analysis proceeds.

Gate 2: Assess the Sampling Completeness

The second decision point is an assessment of the sampling completeness. This is the proportion of the actual cases that are represented by sequenced isolates. The completeness determines the resolution of the transmission inference. A high completeness allows for a detailed reconstruction of the transmission chain. A low completeness creates gaps that can be misinterpreted.

The sampling completeness is estimated by comparing the number of sequenced isolates to the number of reported cases in the outbreak or the study period. The estimate should be recorded as a proportion. The proportion should be reported with the denominator and the numerator. The estimate should also include a description of the case definition used to identify the cases.

The completeness is not the only factor. The distribution of the sampled isolates across time and location is also important. A sample that covers the full time period and all locations is more informative than a sample that is concentrated in one period or one location. The sampling should be documented with a table that lists the isolates, the collection dates, and the locations.

If the completeness is low, the interpretation of the genetic distances must be adjusted. A small distance between two isolates does not prove direct transmission if there are many unsampled cases. The unsampled cases could be the actual links in the chain. The framework should flag the analysis as provisional when the completeness is below a level that the study team defines in advance.

Gate 3: Evaluate the Genetic Distance Against the Threshold

The third decision point is the comparison of the genetic distance between the isolates of interest to the threshold established in Gate 1. The comparison is the core of the genetic evidence. The distance is the number of single nucleotide variants that differ between the isolates. The threshold is the value that separates likely related isolates from likely unrelated isolates.

The comparison should be performed for each pair of isolates in the study. The result is a matrix of distances. The matrix is used to identify the pairs that fall below the threshold. These pairs are the candidates for a transmission link.

The comparison should also include the confidence intervals around the distance. The distance is an estimate. The estimate has uncertainty that comes from the sequencing errors and the variant calling. The confidence interval should be reported. The interval should be used to determine whether the distance is clearly below the threshold or whether it is close to the threshold.

A distance that is clearly below the threshold is a strong signal. A distance that is close to the threshold is a weak signal. The weak signal requires additional evidence before a transmission claim is made.

Gate 4: Assess the Temporal Compatibility

The fourth decision point is the assessment of the temporal compatibility. The genetic distance is a measure of the time since the isolates shared a common ancestor. The time is estimated using the mutation rate. The estimate is compared to the time between the collection dates of the isolates.

The comparison is used to determine whether the genetic distance is consistent with the observed time interval. If the isolates were collected two weeks apart and the genetic distance suggests a divergence time of two years, the transmission is unlikely. If the isolates were collected two weeks apart and the genetic distance suggests a divergence time of two weeks, the transmission is plausible.

The temporal assessment requires a mutation rate. The rate should be specific to the organism and the lineage. The rate should be obtained from the published literature or from a calibration study. The rate should be recorded with its confidence interval.

The temporal assessment is not a proof. The mutation rate is an estimate. The estimate has uncertainty. The uncertainty should be propagated into the time estimate. The time estimate should be reported as a range, not a single value.

Gate 5: Consider the Alternative Explanations

The fifth decision point is the consideration of the alternative explanations. The genetic distance below the threshold is consistent with a transmission link. The link is not the only explanation. The isolates could share a common source that was not sampled. The isolates could be from a single environmental reservoir. The isolates could be from a single contaminated product.

The alternative explanations should be listed and evaluated. The evaluation should use the epidemiological data. The data includes the exposure histories, the locations, and the time periods. The evaluation should determine whether the alternative explanations are plausible.

The alternative explanations are not always easy to rule out. The common source may not be identified. The environmental reservoir may not be sampled. The contaminated product may not be available. The framework should flag the analysis as inconclusive when the alternative explanations cannot be ruled out.

The consideration of the alternative explanations is a critical step. It prevents the overinterpretation of the genetic data. It also guides the next steps in the investigation. The investigation should focus on the alternative explanations when they are plausible.

Gate 6: Document the Decision and the Confidence

The final decision point is the documentation of the conclusion and the confidence level. The conclusion is a statement about the transmission. The confidence is a statement about the strength of the evidence. The confidence should be expressed in a standard format.

The confidence can be expressed as high, moderate, or low. The high confidence is used when the genetic distance is below the threshold, the sampling is complete, the temporal assessment is consistent, and the alternative explanations are ruled out. The moderate confidence is used when one of these conditions is not fully met. The low confidence is used when multiple conditions are not met.

The decision should be documented in a standard format. The documentation should include the isolates, the genetic distance, the threshold, the sampling completeness, the temporal estimate, and the alternative explanations. The documentation should be stored with the study records.

The decision should be reviewed by a second person. The review is a quality control step. The review should be performed by a person who is not directly involved in the analysis. The review should be documented.

Records and Measurements for the Framework

The framework requires a specific set of records. The records should be maintained for each study. The records should include the following:

The baseline genetic diversity distribution with the mean, the range, and the threshold.
The sampling completeness estimate with the numerator and the denominator.
The pairwise genetic distance matrix for all isolates.
The mutation rate and the confidence interval used for the temporal assessment.
The temporal estimate for each pair of isolates.
The list of alternative explanations and the evidence for or against each.
The final decision and the confidence level.

The records should be reviewed at each gate. The review should be documented. The review should be performed by the study team.

Common Failure Patterns in the Decision Process

The framework is designed to prevent common failures. The failures are the overinterpretation of the genetic distance, the ignoring of the sampling bias, the confusion of the genetic cluster with the transmission, and the use of an inappropriate molecular clock. The framework addresses each of these failures.

The overinterpretation is prevented by the baseline and the threshold. The sampling bias is prevented by the completeness assessment. The confusion of the cluster with the transmission is prevented by the alternative explanations. The inappropriate clock is prevented by the temporal assessment.

The framework does not prevent all failures. The framework is only as good as the data and the judgment of the team. The framework should be used as a guide, not as a guarantee.

Professional Escalation Criteria

The framework includes the criteria for escalation. The escalation is required when the analysis is used for a public health action. The escalation is also required when the analysis is used for a clinical decision. The escalation is required when the analysis is not clear or reliable.

The escalation should be performed by the laboratory director or the responsible person. The escalation should be documented. The escalation should be performed in a timely manner. The escalation should be performed when the framework indicates a low confidence or an inconclusive result.

The escalation should be performed when the analysis is beyond the scope of the laboratory. The escalation should be performed when the analysis is not clear. The escalation should be performed when the analysis is not reliable. The escalation should be performed by the laboratory director or the responsible person. The escalation should be documented. The escalation should be performed in a timely manner.

Frequently Asked Questions

How does genetic distance relate to transmission?

Genetic distance is the number of differences between two genomes. A smaller distance indicates a more recent common ancestor. The distance is not a direct measure of transmission. The distance must be interpreted in the context of the mutation rate and the epidemiological data.

What is the role of the mutation rate in transmission inference?

The mutation rate is the rate at which new substitutions accumulate. The rate is used to convert the genetic distance into a time estimate. The rate is not universal and varies by the organism. The rate should be calibrated for the specific organism.

How does sampling bias affect the inference?

Sampling bias is the difference between the sample and the true population. The bias can lead to false clusters or false breaks in the chain. The bias should be minimized by the sampling strategy. The bias should be documented.

Can a phylogenetic tree prove transmission?

A phylogenetic tree shows the genetic relationships between isolates. The tree does not prove transmission. The tree is used to identify potential transmission. The transmission is confirmed by the epidemiological investigation.

What is the difference between a cluster and an outbreak?

A cluster is a group of isolates that are closely related. An outbreak is a group of cases that are epidemiologically linked. A cluster can be an outbreak. The cluster is not an outbreak until it is confirmed by the epidemiological investigation.

How is the quality of the genomic data assessed?

The quality is assessed at each stage of the workflow. The quality of the isolates, the DNA, the sequencing, and the variant calls is assessed. The quality is documented. The quality is used to determine the reliability of the results.

What are the biosafety considerations for the laboratory?

The laboratory should follow the biosafety guidelines. The guidelines are provided by the CDC and NIH. The laboratory should use the appropriate containment and decontamination. The laboratory should be trained in the biosafety.

When should the analysis be escalated to a professional?

The analysis should be escalated when it is used for a public health or clinical decision. The analysis should be escalated when it is not clear or reliable. The analysis should be escalated to a professional with the appropriate expertise.

Using the Evidence

Source	Best use in this topic	Important limitation
Biosafety in Microbiological and Biomedical Laboratories	official guidance	Check the linked page for current local requirements
Microbiology Resources	official guidance	Check the linked page for current local requirements
Antimicrobial Resistance	official guidance	Check the linked page for current local requirements

Related Bacteriology Guides

References and Further Reading

Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
Microbiology Resources. American Society for Microbiology.
Antimicrobial Resistance. World Health Organization.
Bacteriological Analytical Manual. U.S. Food and Drug Administration.
Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute.
Culture Collections. American Type Culture Collection.
NCBI Pathogen Detection. National Center for Biotechnology Information.
Inference of Infectious Disease Transmission through a Relaxed Bottleneck Using Multiple Genomes Per Host.. Molecular biology and evolution, 2024.
Bayesian inference of transmission chains using timing of symptoms, pathogen genomes and contact data.. PLoS computational biology, 2019.
Understanding the biology of monkeypox virus to prevent future outbreaks.. Nature microbiology, 2024.
Genomic Epidemiology, Evolution, and Transmission Dynamics of Porcine Deltacoronavirus.. Molecular biology and evolution, 2020.

This article is educational and does not replace validated laboratory procedures, clinical diagnosis, institutional biosafety review, or public-health guidance.